Paul Perco
Paul Perco
Home
Experience
Accomplishments
Skills
Light
Dark
Automatic
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Hiddo JL Heerspink<sup>*</sup>
,
**Paul Perco<sup>*</sup>**
,
Skander Mulder
,
Johannes Leierer
,
Michael K Hansen
,
Andreas Heinzel
,
Gert Mayer
April 2019
Type
Journal article
Publication
Diabetologia 62(7):
1154-1166
https://doi.org/10.1007/s00125-019-4859-4
Cite
×